Citadel Advisors’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Buy |
186,534
+177,425
| +1,948% | +$99.1K | ﹤0.01% | 5257 |
|
|
2025
Q1 | $4.34K | Sell |
9,109
-511,119
| -98% | -$243K | ﹤0.01% | 5744 |
|
|
2024
Q4 | $525K | Buy |
520,228
+501,742
| +2,714% | +$507K | ﹤0.01% | 3941 |
|
|
2024
Q3 | $31.6K | Sell |
18,486
-26,674
| -59% | -$45.6K | ﹤0.01% | 5232 |
|
|
2024
Q2 | $115K | Sell |
45,160
-9,132
| -17% | -$23.3K | ﹤0.01% | 4897 |
|
|
2024
Q1 | $227K | Sell |
54,292
-45,627
| -46% | -$191K | ﹤0.01% | 4678 |
|
|
2023
Q4 | $332K | Buy |
99,919
+41,328
| +71% | +$137K | ﹤0.01% | 4144 |
|
|
2023
Q3 | $117K | Buy |
58,591
+34,146
| +140% | +$68.3K | ﹤0.01% | 4778 |
|
|
2023
Q2 | $77.2K | Sell |
24,445
-27,755
| -53% | -$87.7K | ﹤0.01% | 4851 |
|
|
2023
Q1 | $181K | Sell |
52,200
-78,958
| -60% | -$274K | ﹤0.01% | 4663 |
|
|
2022
Q4 | $673K | Buy |
+131,158
| New | +$673K | ﹤0.01% | 3586 |
|
|
2022
Q3 | – | Sell |
-59,966
| Closed | -$504K | – | 6280 |
|
|
2022
Q2 | $504K | Buy |
59,966
+27,508
| +85% | +$231K | ﹤0.01% | 4132 |
|
|
2022
Q1 | $409K | Buy |
+32,458
| New | +$409K | ﹤0.01% | 4639 |
|
|
2021
Q4 | – | Sell |
-24,044
| Closed | -$605K | – | 6800 |
|
|
2021
Q3 | $605K | Buy |
+24,044
| New | +$605K | ﹤0.01% | 4325 |
|